In an effort to improve the delivery of therapies for glioblastoma through the blood-brain barrier, new research, presented at the 2013 Annual Meeting of the American Society of Clinical Oncology, evaluates the effectiveness of PVSRIPO, “a live attenuated, oral (SABIN) serotype 1 poliovirus vaccine...